192 filings
Page 2 of 10
8-K
8g33cbnu kjt4vecb6
17 Feb 23
Other Events
4:06pm
8-K
9unsr q0mfb3
9 Jan 23
Travere Therapeutics Provides Corporate Update and 2023 Outlook
7:05am
8-K
enm87kdvmfi
27 Oct 22
Travere Therapeutics Reports Third Quarter 2022 Financial Results
4:17pm
8-K
751 c16yme
13 Oct 22
Other Events
5:05pm
8-K
1fh9sh91exxex
22 Aug 22
Other Events
4:43pm
8-K/A
d6aziwy39i
17 Aug 22
Departure of Directors or Certain Officers
5:20pm
8-K
3owq0ikyh8qnk
4 Aug 22
Travere Therapeutics Reports Second Quarter 2022 Financial Results
7:06am
8-K
sso3mxz
16 May 22
Other Events
4:47pm
8-K
iurq8o
12 May 22
Departure of Directors or Certain Officers
5:26pm
8-K
lojyo 1yi
5 May 22
Travere Therapeutics Reports First Quarter 2022 Financial Results
12:00am
8-K
03su 64ddfx0
20 Apr 22
Departure of Directors or Certain Officers
4:41pm
8-K
csp3wk jf37kkrr5p
21 Mar 22
Other Events
4:09pm
8-K
0dd1u3qmows et3
11 Mar 22
Travere Announces Proposed Convertible Senior Notes Offering
4:06pm
8-K
lca5hz4lblsjqysz8
24 Feb 22
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
12:00am
8-K
4gikevb
10 Jan 22
Travere Therapeutics Provides Corporate Update and 2022 Outlook
7:08am
8-K
c1c ju746hjti5aw
6 Jan 22
Departure of Directors or Certain Officers
4:02pm
8-K
a9jr 36faxq81mnh4i
22 Dec 21
Entry into a Material Definitive Agreement
4:03pm
8-K
iv6r1nopil 0u6g
15 Dec 21
Other Events
5:27pm
8-K
wcvid6m
28 Oct 21
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
4:23pm
8-K
1moh1 ij2ee3pm3cb
12 Oct 21
Departure of Directors or Certain Officers
5:15pm